Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001648627-15-000003
Filing Date
2015-12-24
Accepted
2015-12-24 12:44:21
Documents
1
Effectiveness Date
2015-12-24
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 8689
  Complete submission text file 0001648627-15-000003.txt   9717
Mailing Address 3210 MERRYFIELD ROW SAN DIEGO CA 92121
Business Address 3210 MERRYFIELD ROW SAN DIEGO CA 92121 619-866-4589
Amplyx Pharmaceuticals, Inc. (Filer) CIK: 0001648627 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-251044 | Film No.: 151307624